PETER MOHRER: Open Payments
NPI 1205800463 · GUILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,646 in 43 payments from 8 companies in 2025. Trend: 2023 $14,973 · 2024 $4,814 · 2025 $7,646
Speaker / faculty: $6,750Food & beverage: $884Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $6,907 |
| Vanda Pharmaceuticals Inc. | 2 | $137 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Corium, LLC | 14 | $118 |
| E.R. Squibb & Sons, L.L.C. | 3 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $112 |
| Janssen Pharmaceuticals, Inc | 1 | $100 |
| TMS NeuroHealth Centers Inc. | 1 | $35 |
Products named: VRAYLAR, FANAPT, REXULTI, Azstarys, COBENFY, CAPLYTA, SPRAVATO, TMS NeuroHealth Centers Inc..
Industry payments across CT — which companies pay providers there.
